Article

Docking Molecular analysis of potential Drug Paritaprevir against Mycobacterium tuberculosis (Mtb)

2021-07-10

Abstract excerpt

<h4>Background</h4> Mycobacterium tuberculosis (Mtb) is the causative agent of tuberculosis, which kills 1.8 million annually. This is an infectious disease generally affects the lungs, but can also affect other parts of the body. Mtb RNA polymerase (RNAP) is the target of the first-line antituberculosis drug Rifampin (Rif). We report first time a Potential Drug Paritaprevir against with severe infectious disease...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1153ea40-346d-511a-a2c2-f1cf69fd11bd
DOI: 10.1101/2021.07.09.451739

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Docking Molecular analysis of potential Drug Paritaprevir against Mycobacterium tuberculosis (Mtb)DOI 10.1101/2021.07.09.451739Read

Understanding Rifampicin Resistance in Tuberculosis through a Computational ApproachSemantic proximity Read

Molecular docking, validation, dynamic simulation and pharmacokinetic prediction of natural compounds against <i>Mycobacterium tuberculosis</i> Beta-lactamase BlaCSemantic proximity Read

Computational analysis of RNA methyltransferase Rv3366 as a potential drug target for combating drug-resistant Mycobacterium tuberculosisSemantic proximity Read

Exploration of potential inhibitors for tuberculosis via structure‐based drug design, molecular docking, and molecular dynamics simulation studiesSemantic proximity Read

Molecular docking, molecular dynamics simulations and binding free energy studies of interactions between Mycobacterium tuberculosis Pks13, PknG and bioactive constituents of extremophilic bacteriaSemantic proximity Read

Computational approaches: Atom-based 3D-QSAR, molecular docking, ADME-Tox, MD simulation and DFT to find novel multi-targeted Anti-tubercular agentsSemantic proximity Read

Hybrid Dynamic Pharmacophore Models as Effective Tools to Identify Novel Chemotypes for Anti-tb Inhibitor Design: a Case Study With Mtb-dapbSemantic proximity Read

Application of Computational Methods in Understanding Mutations in Mycobacterium tuberculosis Drug ResistanceSemantic proximity Read

Molecular Modeling of Mycobacterium Tuberculosis DNA Gyrase and its Molecular Docking Study with Gatifloxacin InhibitorsSemantic proximity Read

Target Prediction for an Open Access Set of Compounds Active against Mycobacterium tuberculosisSemantic proximity Read

Structure-based in silico approaches for drug discovery against Mycobacterium tuberculosisSemantic proximity Read

Computational modeling and bioinformatic analyses of functional mutations in drug target genes in Mycobacterium tuberculosisSemantic proximity Read